Obstetrics & Gynecology Science

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth

Eun Ju Lee, Ki Hoon Ahn, Soon Cheol Hong, Eun Hee Lee, Yong Park, Byung Soo Kim

Obstet Gynecol Sci. 2014;57(6):526-529. Published online November 20, 2014
DOI: https://doi.org/10.5468/ogs.2014.57.6.526

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth

Eun Ju Lee, Ki Hoon Ahn, Soon Cheol Hong, Eun Hee Lee, Yong Park, Byung Soo Kim

Obstetrics & Gynecology Science. 2014;57(6):526

Link1 Link2 Link3

Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma

Myrna Candelaria, Alfonso Dueñas-Gonzalez

Therapeutic Advances in Hematology. 2021;12:204062072198957

Link1 Link2 Link3

Successful Treatment of Diffuse Large B-Cell Non-Hodgkin Lymphoma with Modified CHOP (Cyclophosphamide/Doxorubicin/Vincristine/ Prednisone) Chemotherapy and Rituximab in a Patient with Nijmegen Syndrome

Miroslav Dumic, Ivo Radman, Nevena Krnic, Marin Nola, Rajko Kusec, Davor Begovic, Boris Labar, Marko Rados

Clinical Lymphoma and Myeloma. 2007;7(9):590-593

Link1 Link2

Erratum: Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

Cancer. 2011;118(13):3446-3446

Link1 Link2

Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)

Guoqi Song, Huiyun Ni, Linqing Zou, Shukui Wang, Fuliang Tian, Hong Liu, William Cho

OncoTargets and Therapy. 2016;3799

Link1

Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma

S. Wöhrer, A. Püspök, J. Drach, M. Hejna, A. Chott, M. Raderer

Annals of Oncology. 2004;15(7):1086-1090

Link1 Link2 Link3

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

Alberto Febbri, Alessandro Gozzetti, Luigi Rigacci

Cancer. 2011;117(15):3530-3530

Link1 Link2

Reply to activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

Antonino Musolino, Daniela Boggiani, Michele Panebianco

Cancer. 2011;117(15):3531-3531

Link1 Link2

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma

John C. Hornberger, Jennie H. Best

Cancer. 2005;103(8):1644-1651

Link1 Link2

Antonino Musolino, Daniela Boggiani, Michele Panebianco, Giovanna Vasini, Stefania Salvagni, Vittorio Franciosi, Andrea Ardizzoni

Cancer. 2010;117(5):964-973

Link1 Link2